Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT04210791
Autologous Stem Cell Transplantation for Patients With AL Amyloidosis
Sponsor: Nanjing University School of Medicine
View on ClinicalTrials.gov
Summary
This study mainly evaluated the efficacy and safety of autologous stem cell transplantation for the treatment of AL amyloidosis, the role of induction and maintenance therapy in autologous stem cell transplantation, and the long-term efficacy and prognosis risk factors of autologous stem cell transplantation for the treatment of AL amyloidosis.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2010-07-01
Completion Date
2030-12-31
Last Updated
2024-02-26
Healthy Volunteers
No
Conditions
Locations (1)
National Clinical Research Center of Kidney Diseases, Jinling Hospital
Nanjing, Jiangsu, China